We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 4,033 results
  1. Administration of USP7 inhibitor p22077 alleviates Angiotensin II (Ang II)-induced atrial fibrillation in Mice

    Atrial fibrillation (AF), the most common cardiac arrhythmia, is an important contributor to mortality and morbidity. Ubquitin-specific protease 7...

    Yu Wang, Yu-Hui Gu, ... Hai-Lian Bi in Hypertension Research
    Article 19 February 2024
  2. Evaluation of angiotensin converting enzyme 2 (ACE2), angiotensin II (Ang II), miR-141-3p, and miR-421 levels in SARS-CoV-2 patients: a case-control study

    Background

    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly contagious virus that uses angiotensin converting enzyme 2 (ACE2),...

    Ehsan Kakavandi, Kaveh Sadeghi, ... Jila Yavarian in BMC Infectious Diseases
    Article Open access 22 April 2024
  3. Enhancement of angiotensin II type 1 receptor-associated protein in the paraventricular nucleus suppresses angiotensin II-dependent hypertension

    The renin-angiotensin system in the brain plays a pivotal role in modulating sympathetic nerve activity and contributes to the pathogenesis of...

    Mari Sotozawa, Sho Kinguchi, ... Kouichi Tamura in Hypertension Research
    Article 26 October 2023
  4. Angiotensin II type 1 receptor-associated protein deletion combined with angiotensin II stimulation accelerates the development of diabetic kidney disease in mice on a C57BL/6 strain

    The progress in the research field of diabetic kidney disease (DKD) has been disturbed by the lack of reliable animal models. Angiotensin II (Ang II)...

    Shinya Taguchi, Kengo Azushima, ... Kouichi Tamura in Hypertension Research
    Article 13 November 2023
  5. Angiotensin II and post-streptococcal glomerulonephritis

    Background

    Post-streptococcal glomerulonephritis (PSGN) is a consequence of the infection by group A beta-hemolytic streptococcus. During this...

    Jesus A. Mosquera-Sulbaran, Adriana Pedreañez, ... Juan Pablo Hernandez-Fonseca in Clinical and Experimental Nephrology
    Article 03 January 2024
  6. Transmembrane protein 117 knockdown protects against angiotensin-II-induced cardiac hypertrophy

    Mitochondrial dysfunction plays a critical role in the pathogenesis of pathological cardiac hypertrophy. Transmembrane protein 117 modulate...

    Yi Yang, **nquan Wang, ... Peijian Wang in Hypertension Research
    Article Open access 24 July 2023
  7. Impaired angiotensin II signaling in septic shock

    Recent years have seen a resurgence of interest for the renin–angiotensin–aldosterone system in critically ill patients. Emerging data suggest that...

    Adrien Picod, Bruno Garcia, ... Feriel Azibani in Annals of Intensive Care
    Article Open access 14 June 2024
  8. ACE inhibitors and angiotensin receptor blockers differentially alter the response to angiotensin II treatment in vasodilatory shock

    Background

    Angiotensin-converting enzyme inhibitor (ACEi) and angiotensin receptor blockers (ARB) medications are widely prescribed. We sought to...

    Daniel E. Leisman, Damian R. Handisides, ... Rinaldo Bellomo in Critical Care
    Article Open access 18 April 2024
  9. Mitochondrial fission inhibition protects against hypertension induced by angiotensin II

    Mitochondrial dysfunction has been implicated in various types of cardiovascular disease including hypertension. Mitochondrial fission fusion balance...

    Kyle J. Preston, Tatsuo Kawai, ... Satoru Eguchi in Hypertension Research
    Article 21 February 2024
  10. Insights into the associative role of hypertension and angiotensin II receptor in lower urinary tract dysfunction

    In men, the lower urinary tract comprises the urinary bladder, urethra, and prostate, and its primary functions include urine storage and voiding....

    Shogo Shimizu in Hypertension Research
    Article 14 February 2024
  11. Angiotensin ii therapy in refractory septic shock: which patient can benefit most? A narrative review

    Patients with septic shock who experience refractory hypotension despite adequate fluid resuscitation and high-dose noradrenaline have high mortality...

    Irene Coloretti, Andrea Genovese, ... Nathan D. Nielsen in Journal of Anesthesia, Analgesia and Critical Care
    Article Open access 21 February 2024
  12. Celastrol attenuates streptozotocin-induced diabetic cardiomyopathy in mice by inhibiting the ACE / Ang II / AGTR1 signaling pathway

    Background

    Heart failure is closely correlated with diabetic cardiomyopathy (DCM) and can lead to mortality. Celastrol has long been utilized for the...

    Xuyong Zhao, Bingwu Huang, ... Ning Zhu in Diabetology & Metabolic Syndrome
    Article Open access 12 September 2023
  13. miPEP31 alleviates Ang II-induced hypertension in mice by occupying Cebpα binding sites in the pri-miR-31 promoter

    Background

    Previous studies have shown that peptides encoded by noncoding RNAs (ncRNAs) can be used as peptide drugs to alleviate diseases. We found...

    **angxiao Li, Hong Zhou, ... Qun Li in Cardiovascular Diabetology
    Article Open access 11 July 2024
  14. Angiotensin II treatment is associated with improved oxygenation in ARDS patients with refractory vasodilatory shock

    Background

    The physiological effects of renin-angiotensin system modulation in acute respiratory distress syndrome (ARDS) remain controversial and...

    Daniel E. Leisman, Damian R. Handisides, ... Rinaldo Bellomo in Annals of Intensive Care
    Article Open access 16 December 2023
  15. Infused juice concentrate of Japanese plum Prunus mume attenuates inflammatory vascular remodeling in a mouse model of hypertension induced by angiotensin II

    Fruit from the Prunus mume tree is a traditional food in Japan. Recently, bainiku-ekisu, an infused juice concentrate of Japanese Prunus mume , is...

    Keisuke Okuno, Keiichi Torimoto, ... Satoru Eguchi in Hypertension Research
    Article 13 June 2023
  16. Protective Effect and Mechanism of Kuntai Capsule on Angiotensin II -Induced Hypertension in Ovariectomized Rats

    Objective

    To explore the protective effect and mechanism of Kuntai (KT) Capsule on angiotensin II (Ang II)-induced hypertension in ovariectomized...

    **ao-fen Ge, Sha-sha Li, ... **ao-wan Sun in Chinese Journal of Integrative Medicine
    Article 03 November 2022
  17. Impaired renal autoregulation and pressure-natriuresis: any role in the development of heart failure in normotensive and angiotensin II-dependent hypertensive rats?

    The aim of the present study was to assess the autoregulatory capacity of renal blood flow (RBF) and of the pressure-natriuresis characteristics in...

    Zuzana Honetschlägerová, Janusz Sadowski, ... Luděk Červenka in Hypertension Research
    Article Open access 17 August 2023
  18. The protective effects of hyperoside on Ang II-mediated apoptosis of bEnd.3 cells and injury of blood-brain barrier model in vitro

    Background

    Hypertension and its associated dysfunction of the blood-brain barrier (BBB) are considered to contribute to cerebral small vessel disease...

    Yu Yan **e, Yun Wei Lu, Gu Ran Yu in BMC Complementary Medicine and Therapies
    Article Open access 13 June 2022
  19. Angiotensin II-induced a steeper blood pressure elevation in IL-23 receptor-deficient mice: Role of interferon-γ-producing T cells

    A subset of interleukin (IL)-17A-producing γδ T cells called γδT17 cells may contribute to progression of hypertension. γδT17 cell development is in...

    Brandon G. Shokoples, Kevin Comeau, ... Ernesto L. Schiffrin in Hypertension Research
    Article 15 October 2022
  20. Angiotensin II

    Rinaldo Bellomo, Alexander Zarbock, Giovanni Landoni in Intensive Care Medicine
    Article 08 January 2024
Did you find what you were looking for? Share feedback.